About India IVF
India IVF is a leading provider of assisted reproductive healthcare services, specializing in IVF, ICSI, egg donation, surrogacy, and other fertility treatments. With a network of state-of-the-art clinics across India, India IVF is committed to providing high-quality, affordable fertility solutions, helping couples realize their dream of parenthood.
For more Information visit: https://indiamedtoday.com/india-ivf-secures-1-25-million-investment-from-tomorrowcapital/#:~:text=India%20IVF%2C%20a%20pioneering%20fertility,stage%2C%20transformative%20consumer%20healthcare%20businesses.
India IVF, a pioneering fertility provider in India, has successfully raised $1.25 million in investment from Tomorrow Capital, a prominent venture fund. This strategic funding will significantly enhance the company’s ability to expand its services, upgrade its state-of-the-art facilities, and invest in cutting-edge technology to improve patient care and outcomes.
The investment is poised to accelerate India IVF’s mission of making high-quality fertility treatments more accessible to families across India and beyond. With a proven track record of successful IVF treatments the orgianisation aims to further solidify its position as a trusted leader in the fertility space.
The investment represents India IVF’s first external funding since its inception, following a decade of profitable operations across its five North Indian centers, which include clinics in Delhi NCR and Srinagar.
The new funding from Tomorrow Capital will drive India IVF’s expansion across North India, enabling the company to bridge critical gaps in fertility care access. With the goal of making advanced fertility solutions accessible to underserved communities, India IVF has established India’s first tech-enabled fertility platform, offering comprehensive, 360-degree fertility care through advanced technology and a dedicated team of experts. Tomorrow Capital’s investment follows its recent support of VitusCare and IndiShreshtha, further reinforcing its commitment to specialized healthcare ventures.
Rahul Saha, Senior Principal, Tomorrow Capital said, “India IVF has shown remarkable growth and a deep understanding of the unique fertility challenges faced by many Indian couples. With a tech-enabled, patient-focused approach, they deliver high-quality personalizsed care, addressing the often-emotional and stigma-attached journey of fertility treatment. Tomorrow Capital backs ventures that drive meaningful impact, and with India IVF, we’re proud to enable access to essential fertility care across underserved regions in India. We believe their innovative approach will set new standards in India’s fertility sector, and we are excited to support their mission to make fertility care more accessible across the country.”
Dr Somendra Shukla, Co-Founder and CEO, India IVF, commented, “This partnership will empower us to expand our network and bring advanced fertility solutions to more communities. We look forward to making a positive impact on more families and growing India IVF into a trusted national brand.”
India IVF plans to use the capital to provide holistic, 360-degree fertility care through advanced technology and a dedicated team of experts.
“India IVF has a deep understanding of the unique fertility challenges faced by Indian couples. We are proud to support their mission to expand access to quality fertility care across underserved regions,” Rahul Saha, senior principal at Tomorrow Capital, told India Med Today.
About Tomorrow Capital
Tomorrow Capital is a global venture capital firm focused on investing in groundbreaking healthcare companies. The firm backs innovative businesses that address critical challenges in the healthcare sector, particularly those that leverage technology to improve patient care. Tomorrow Capital’s portfolio spans across various sectors, including biotechnology, digital health, medical devices, and diagnostics.
Plans for the Future
Looking ahead, India IVF is focused on building a strong digital infrastructure to offer virtual consultations, telemedicine, and other online services, further increasing accessibility for patients in remote areas. The company also plans to enhance its research capabilities and expand its partnerships with international fertility centers, positioning India IVF as a global leader in assisted reproductive technology.
“We are excited about the future of fertility care in India and the opportunity to help more people achieve their dreams of becoming parents,” Dr. Kumar said. “With the backing of Tomorrow Capital, we are confident that we will continue to innovate and expand our services to meet the evolving needs of our patients.”
